1. Home
  2. KDP

as of 03-17-2026 3:54pm EST

$27.55
$0.00
0.00%
Stocks Consumer Staples Beverages (Production/Distribution) Nasdaq

Keurig Dr Pepper was established in 2018 following a merger between Keurig Green Mountain Coffee and Dr Pepper Snapple. The company manufactures and distributes coffee systems (including coffee brewers and single-serve coffee pods) under the Keurig and Green Mountain brands, as well as ready-to-drink beverages including flavored (non-cola) sparkling soft drinks under well-known brands such as Dr Pepper, Snapple, and Canada Dry. The company controls production and route to market for its own brands through in-house manufacturing plants and distribution infrastructure and leverages these facilities to manufacture and distribute for third-party coffee and beverage brands via licensing and partnership agreements. The US and Canada make up 95% of revenue, with the rest from Mexico.

Founded: 1981 Country:
United States
United States
Employees: N/A City: BURLINGTON
Market Cap: 37.4B IPO Year: 2007
Target Price: $35.47 AVG Volume (30 days): 8.4M
Analyst Decision: Buy Number of Analysts: 17
Dividend Yield:
3.32%
Dividend Payout Frequency: quarterly
EPS: 1.53 EPS Growth: 45.71
52 Week Low/High: $25.03 - $36.12 Next Earning Date: 05-29-2026
Revenue: $16,603,000,000 Revenue Growth: 8.16%
Revenue Growth (this year): 59.13% Revenue Growth (next year): 14.18%
P/E Ratio: 18.11 Index:
Free Cash Flow: 1.5B FCF Growth: -9.12%

AI-Powered KDP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 21 hours ago

AI Recommendation

hold
Model Accuracy: 71.52%
71.52%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2025
Q4

Q4 2025 Earnings

8-K SELL

Feb 24, 2026 · 100% conf.

AI Prediction SELL

1D

-0.79%

$30.78

Act: -2.84%

5D

-4.22%

$29.72

Act: -4.71%

20D

-2.75%

$30.18

Price: $31.03 Prob +5D: 0% AUC: 1.000
0001418135-26-000011

kdp-202602240001418135FALSE00014181352026-02-242026-02-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2026

Keurig Dr Pepper Inc. (Exact name of registrant as specified in its charter)

Delaware001-3382998-0517725 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

6425 Hall of Fame Lane, Frisco, Texas 75034 (Address of principal executive offices, including zip code) (800) 527-7096 (Registrant's telephone number including area code) Not Applicable (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Common stockKDPThe Nasdaq Stock Market LLC

Item 2.02. Results of Operations and Financial Condition. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing. On February 24, 2026, Keurig Dr Pepper Inc. (the "Company" or "KDP") issued a press release announcing the Company's financial results for the fourth quarter and full year ended 2025. A copy of such press release is attached as Exhibit 99.1 and is also available on the Company's website at http://www.keurigdrpepper.com. Item 9.01. Financial Statements and Exhibits.

Exhibit No.Description

99.1 Keurig Dr Pepper Inc. Press Release dated February 24, 2026 - "Keurig Dr Pepper Reports Q4 and Full Year 2025 Results and Provides 2026 Outlook"

104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

KEURIG DR PEPPER INC.

Dated: February 24, 2026

By:/s/ Anthony Shoemaker Name:Anthony Shoemaker Title:Chief Legal Officer, General Counsel and Secretary

2025
Q3

Q3 2025 Earnings

8-K

Oct 27, 2025

0001418135-25-000118

kdp-202510270001418135FALSE00014181352025-10-272025-10-27

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2025

Keurig Dr Pepper Inc. (Exact name of registrant as specified in its charter)

Delaware001-3382998-0517725 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

53 South Avenue, Burlington, Massachusetts 01803 (Address of principal executive offices, including zip code) 877-208-9991 (Registrant's telephone number including area code) Not Applicable (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Common stockKDPThe Nasdaq Stock Market LLC

Item 2.02. Results of Operations and Financial Condition. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing. On October 27, 2025, Keurig Dr Pepper Inc. (the "Company" or "KDP") issued a press release announcing the Company's financial results for the third quarter of 2025. A copy of such press release is attached as Exhibit 99.1 and is also available on the Company's web site at http://www.keurigdrpepper.com. Item 9.01. Financial Statements and Exhibits.

Exhibit No.Description

99.1 Keurig Dr Pepper Inc. Press Release dated October 27, 2025 - "Keurig Dr Pepper Reports Q3 2025 Results and Raises Full Year Net Sales Outlook and Reaffirms EPS Guidance for 2025"

104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

KEURIG DR PEPPER INC.

Dated: October 27, 2025

By:/s/ Anthony Shoemaker Name:Anthony Shoemaker Title:Chief Legal Officer, General Counsel and Secretary

2025
Q2

Q2 2025 Earnings

8-K

Jul 24, 2025

0001418135-25-000102

kdp-202507240001418135FALSE00014181352025-07-242025-07-24

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2025

Keurig Dr Pepper Inc. (Exact name of registrant as specified in its charter)

Delaware001-3382998-0517725 (State or other jurisdiction of incorporation)(Commission File Number)(IRS Employer Identification No.)

53 South Avenue, Burlington, Massachusetts 01803 (Address of principal executive offices, including zip code) 877-208-9991 (Registrant’s telephone number including area code) Not Applicable (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Common stockKDPThe Nasdaq Stock Market LLC

Item 2.02. Results of Operations and Financial Condition. The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such a filing. On July 24, 2025, Keurig Dr Pepper Inc. (the "Company" or "KDP") issued a press release announcing the Company's financial results for the second quarter of 2025. A copy of such press release is attached as Exhibit 99.1 and is also available on the Company’s web site at http://www.keurigdrpepper.com.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.Description

99.1 Keurig Dr Pepper Inc. Press Release dated July 24, 2025 - "Keurig Dr Pepper Reports Q2 2025 Results and Reaffirms Guidance for 2025"

104Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

KEURIG DR PEPPER INC.

Dated: July 24, 2025

By:/s/ Anthony Shoemaker Name:Anthony Shoemaker Title:Chief Legal Officer, General Counsel and Secretary

Latest Keurig Dr Pepper Inc. News

KDP Breaking Stock News: Dive into KDP Ticker-Specific Updates for Smart Investing

All KDP News

Share on Social Networks: